Water Cooler Podcast

Why Clinical Trials Break and How to Spot the Early SignsIn this episode, Suzanne Vyvoda shares expert insights into why clinical trials often encounter delays and budget overruns, and how sponsors can identify signals early to get ahead of issues. Whether you're new to clinical research or a seasoned professional, these practical tips can help you improve trial management and avoid costly setbacks.Key Topics:The common operational causes of clinical trial delaysHow to interpret early signals that a trial is falling off trackThe importance of realistic assumptions in trial planningThe role of data dashboards in monitoring trial healthNon-data signs of trouble, like site frustration and slow decision-makingStrategic steps before the first patient is enrolled to prevent issuesThe critical role of operational strategy in trial success

This episode is about how small biotechs should manage CROs and vendors more strategically. Niharika’s main point is that outsourcing is not hands off. Sponsors still need strong oversight, better budget transparency, and clear goals with vendors. She also says AI can improve things like site selection, reporting, and monitoring support, but it cannot replace human judgment in clinical operations.

In this episode, Richard Steinfeld interviews Arpit Chokshi, who shares his experiences and challenges in the job market, particularly in the life sciences sector. Arpit discusses the emotional toll of job searching, the surprising difficulties in finding opportunities, and the impact of applicant tracking systems on job applications. He emphasizes the importance of networking, tailoring resumes, and learning from rejections while providing valuable insights for others in similar situations.

In this episode, Richard Steinfeld interviews Suresh Dheerendra, Senior Vice President of Clinical Operations at Neuron 23. They discuss the complexities of clinical trials, focusing on patient enrollment, retention challenges, and the importance of site activation. Suresh shares insights on the multifaceted nature of enrollment risks, the significance of building relationships with sites, and the innovative strategies being employed to enhance patient engagement and retention. The conversation also touches on the evolving role of technology in clinical operations and the need for companies to adapt to new advancements.

I sat down with David Tsai for a es first post, and how it has grown since then.I have known David since I began my own journey, and he has become a good friend. His spirit and kindness come through clearly in this conversation.David is a gem in the life sciences space, and rooting for his success is easy. If you enjoy the conversation, I hope you will give him a like and follow him on LinkedIn.

Vaccines are facing renewed skepticism, and the consequences are showing up in real time. In this episode, we break down why vaccines have come under attack, how misinformation spreads, and why declining vaccination rates are linked to outbreaks of preventable illnesses like measles and whooping cough. We also discuss the COVID 19 vaccine, how the conversation became polarized, and what it means for personal health and community protection.

The Water Cooler Podcast is real talk about life science. Host Richard Steinfeld sits with scientists, executives, regulators, investors, clinicians, and biostats pros to unpack how work really gets done. Clear stories, useful takeaways, zero fluff.